Trevi Therapeutics (TRVI) Tops Q3 EPS by 5c
Trevi Therapeutics (NASDAQ: TRVI) reported Q3 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Trevi Therapeutics (NASDAQ: TRVI) reported Q3 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.